Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor. BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression Targeting PAD4 may be beneficial for treatment of multiple myeloma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 82.00 | |
10 mg | In stock | $ 145.00 | |
25 mg | In stock | $ 297.00 | |
50 mg | In stock | $ 533.00 | |
100 mg | In stock | $ 759.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 85.00 |
Description | BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor. BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression Targeting PAD4 may be beneficial for treatment of multiple myeloma. |
In vivo | Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression. |
Molecular Weight | 472.58 |
Formula | C27H32N6O2 |
CAS No. | 1550371-22-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (21.16 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-P5 free base 1550371-22-6 Chromatin/Epigenetic PAD BMS-P-5 free base BMS P5 free base myeloma Inhibitor inhibit BMS-P5 Protein Arginine Deiminase Multiple NET BMSP5 free base Peptidylarginine Deiminase inhibitor